Taysha Gene Therapies (TSHA) announced that, on March 3, 2025, the Compensation Committee of Taysha’s Board of Directors granted three new ...
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
TipRanks on MSN4d
TGS Announces Vesting of Restricted Share UnitsTGS Nopec Geophysical Company ASA ( ($GB:0MSJ) ) just unveiled an update. TGS Nopec Geophysical Company ASA announced the vesting of 15,000 ...
However, in mid-2021, the company accelerated the vesting of awards, or allowed continued vesting, for six departing employees and retiring directors. ASC 718 requires companies to re-value stock ...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement ...
Vesting of the stock option is subject to such employee's continued service to Taysha on each vesting date. About Taysha Gene Therapies Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback